Phase II trial of nab-paclitaxel and carboplatin with concurrent radiotherapy for patients with locally advanced non-small cell lung cancer - Phase II trial of nab-paclitaxel and carboplatin with concurrent radiotherapy for patients with locally advanced non-small cell lung cancer

Department of Radiation Oncology, Yamaguchi University Hospital0 sites37 target enrollmentNovember 2, 2015

Overview

No summary available.

Registry

who.int

Start Date

November 2, 2015

End Date

April 26, 2017

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Department of Radiation Oncology, Yamaguchi University Hospital

•1\. Patient with a history of allergy to taxane antineoplastic agents 2\. Patient with a history of allergy to carboplatin or other platinum\-based antineoplastic agents 3\. Patient with a history of allergy to albumin 4\. without the concent to the risk of infection caused by albumin preparation 5\. Patients with active infection 6\. Patients with serious complications (e.g. heart failure, severe pulmonary emphysema, renal disfunction, hepatic disfunction, poorly controlled diabetes or hypertension) 7\. Patient with severe bone marrow suppression 8\. Patient with active double cancer within 5years prior to the study 9\. Patients with pleural or pericardial effusion, or ascites. 10\. Patient with motor paralysis or neuropathy, except due to NSCLC 11\. Exhibiting significant interstitial pneumonitis, or pulmonary fibrosis in the chest radiograph 12\. Patient with collagen vascular diseases 13\. Female Patient in or having a chance or planning of pregnancy or breast feeding 14\. Male patient in planning to impregnate 15\. Inappropriate patients for this study judged by the attending physician